... 10 and 16 h are signed as Nafion/S-SiO
2
-4 h, Nafion/S-SiO
2
-
10h and Nafion/S-SiO
2
-1 6h, respectively. For the ex-situ research of the mechanism of
sulfonation, the powder of SiO
2
nano-particles ...
located in 100 0-1 100 cm
-1
, which coincides with the strong absorption band of symmetric
and anti-symmetric vibration of the Si-O-Si. For this reason, th...
...
(mA)
BRP-1a 0.122 0.011
BRP-1b 0.096 0.012
BRP-1c 0.114 0.013
BRP-2a 0.089 0.009
BRP-2b 0.092 0.009
BRP-2c 0 .102 0.009
SAA-1a 0. 110 0.011
SAA-1b 0.079 0. 010
SAA-1c 0.088 0.011
SAA-2a 0.083 ... pulse-
mode operation with discrimination of gamma-ray pulses was possible in a gamma-ray field
of approximately 433 Gy Si h
-1
at a thermal-neutron fluence rate of 3.59 x 10...
... Thisfigure rep-
resents a decline of about one-third from the early
1970’s. The rate of decline has leveled off from the
late 1980’s but is projected to continue because of op-
position to the use of asbestos ... Commercial depos-
its of chrysotile occur in ultramafic rocks, particu-
larly peridotite, that have undergonemetamorphism.
The five other forms of asbestos are members o...
... published forecasts of general economic
conditions and had produced tax revenue forecasts for internal use of the state’s De-
partment of Management by judgmentally adjusting the product of a large commercial
forecaster. ... state policymakers, one of the members of the REC dur-
ing the 1990s, Director of the Department of Management, Gretchen Tegler remarked,
“It lets the dec...
... polymorphically distributed, with about 7% of
European- and African-derived populations (but very few Asians) displaying the
PM phenotype (Fig. 5-6 ). Dozens of loss -of- function variants in the CYP2D6 ... drug effects. However,
loss -of- function alleles in these genes have not yet been described.
Chapter 005. Principles of Clinical
Pharmacology
(Part 8)
Principles of...
... the HMG-CoA reductase
gene as predicting efficacy of HMG-CoA reductase inhibitors, and in variants in
the gene-encoding corticotrophin-releasing hormone receptor 1 as predicting
efficacy of inhaled ... associated with variability in the
effect of a single drug. CYP2C9 loss -of- function variants are associated with a
requirement for lower maintenance doses of the vitamin K antago...
... genetics, clinical trials, and the educated prescriber all
Chapter 005. Principles of Clinical
Pharmacology
(Part 14)
Diagnosis and Treatment of Adverse Drug Reactions
The manifestations of drug-induced ... manifestations of drug-induced diseases frequently resemble those of
other diseases, and a given set of manifestations may be produced by different and
dissimila...
...
Figure 2 9-8
Chapter 029. Disorders of the Eye
(Part 10)
Central retinal artery occlusion combined with ischemic optic
neuropathy in a 19-year-old woman with an elevated titer of anticardiolipin ... scattered flame (splinter) hemorrhages
and cotton-wool spots (nerve fiber layer infarcts) in a patient with headache and a
blood pressure of 234/120.
Impending branch or centr...
... support to the hypothesis that the pattern is the result of the migration of
two clones of primordial melanocytes, each with a different pigment potential.
Localized areas of decreased pigmentation ... and lance-ovate. Examination of the patient for
additional cutaneous signs such as multiple angiofibromas of the face (adenoma
sebaceum), ungual and gingival fibromas, fibrous p...
... to have N2 disease
Stage IB: discussion of risk/benefits of adjuvant CRx; not routinely given
Chapter 085. Neoplasms of the Lung
(Part 10)
Staging of Small Cell Lung Cancer
Pretreatment ... performed as part of the physiologic
evaluation. This test allows an estimate of the maximal oxygen consumption
(Ṽ
O2
max). A Ṽ
O2
max <15 mL/kg per min predicts for high risk...